Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 35Gastrointestinal 24Thoracic 8Tumor-Agnostic 7Gynecologic 7Head & Neck 6Other hematologic neoplasm 5Genitourinary 5Lymphoid 2Endocrine 2Sarcoma 1Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other 1NET 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Osteolysis 1Multiple Myeloma 1Motor Activity 1

Interventions

Cyclophosphamide 20fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Dexamethasone 13Cyclosporine 12Whole-Body Irradiation 11fludarabine 10Exercise 10Antilymphocyte Serum 10Melphalan 9Busulfan 9Blood Specimen Collection 9Mycophenolic Acid 8Therapeutics 7Filgrastim 7Bortezomib 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6pomalidomide 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5daratumumab 4Surveys and Questionnaires 4Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Control Groups × Plasma cell × Clear all
NCT07026799 2025-06-18

GMMG-HD8-INDEX

University Hospital Heidelberg

Phase NA Active not recruiting
50 enrolled
Plasma cell

Motor Activity, Multiple Myeloma, Osteolysis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡